DC Subsets Regulate Humoral Immune Responses by Supporting the Differentiation of Distinct Tfh Cells.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 21 01 2019
accepted: 07 05 2019
entrez: 14 6 2019
pubmed: 14 6 2019
medline: 25 8 2020
Statut: epublish

Résumé

To determine the contribution of skin DC subsets in the regulation of humoral immunity, we used a well-characterized antigen targeting system to limit antigen availability and presentation to certain skin-derived DC subsets. Here we show that delivery of foreign antigen to steady state Langerhans cells (LCs) and cDC1s through the same receptor (Langerin) led to, respectively, robust vs. minimal-to-null humoral immune response. LCs, unlike cDC1s, supported the formation of germinal center T follicular helper cells (GC-Tfh) antigen dose-dependently and then, likely licensed by these T cells, some of the LCs migrated to the B cell area to initiate B cell responses. Furthermore, we found that the cDC1s, probably through their superior T cell activation capacity, prevented the LCs from inducing GC-Tfh cells and humoral immune responses. We further show that targeted delivery of cytokines to DCs can be used to modulate DC-induced humoral immune responses, which has important therapeutic potential. Finally, we show that human LCs, unlike monocyte-derived DCs, can support GC Tfh generation in an

Identifiants

pubmed: 31191525
doi: 10.3389/fimmu.2019.01134
pmc: PMC6545976
doi:

Substances chimiques

HIV Core Protein p24 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1134

Références

J Immunol. 1999 Mar 15;162(6):3428-36
pubmed: 10092798
J Leukoc Biol. 1999 Aug;66(2):224-30
pubmed: 10449158
J Immunol. 2000 Feb 15;164(4):1847-54
pubmed: 10657633
Immunology. 2000 May;100(1):1-3
pubmed: 10809952
J Leukoc Biol. 2001 Oct;70(4):633-41
pubmed: 11590201
J Exp Med. 1992 Jan 1;175(1):15-21
pubmed: 1370527
Immunity. 2005 Nov;23(5):503-14
pubmed: 16286018
Immunity. 2005 Dec;23(6):611-20
pubmed: 16356859
J Exp Med. 2006 Apr 17;203(4):1081-91
pubmed: 16606676
Science. 2006 Jun 16;312(5780):1672-6
pubmed: 16778060
Cell Tissue Res. 2007 Jan;327(1):83-92
pubmed: 16941124
Immunity. 2007 Apr;26(4):491-502
pubmed: 17379546
Immunity. 2008 Sep 19;29(3):497-510
pubmed: 18789730
J Exp Med. 2008 Nov 24;205(12):2873-86
pubmed: 18981236
Nat Rev Immunol. 2009 Jan;9(1):15-27
pubmed: 19079135
Nat Immunol. 2009 Apr;10(4):375-84
pubmed: 19252493
Nat Immunol. 2009 May;10(5):488-95
pubmed: 19349986
Immunity. 2009 Sep 18;31(3):491-501
pubmed: 19733096
J Immunol. 2009 Oct 15;183(8):5085-93
pubmed: 19801524
J Exp Med. 2010 Jan 18;207(1):189-206
pubmed: 20038600
Nat Rev Immunol. 2010 Mar;10(3):170-81
pubmed: 20154735
Annu Rev Immunol. 2010;28:185-210
pubmed: 20192804
J Exp Med. 2010 Apr 12;207(4):823-36
pubmed: 20351058
Annu Rev Immunol. 2011;29:621-63
pubmed: 21314428
Immunity. 2011 Aug 26;35(2):260-72
pubmed: 21782478
Trends Immunol. 2012 Feb;33(2):71-7
pubmed: 22153931
J Exp Med. 2012 Jan 16;209(1):109-21
pubmed: 22213806
Immunity. 2012 May 25;36(5):873-84
pubmed: 22560445
Nat Immunol. 2012 May 27;13(7):681-90
pubmed: 22634865
J Immunol. 2012 Aug 1;189(3):1294-302
pubmed: 22753938
J Immunol. 2012 Sep 1;189(5):2645-55
pubmed: 22865916
J Exp Med. 2012 Sep 24;209(10):1825-40
pubmed: 22966002
PLoS One. 2012;7(11):e45680
pubmed: 23226194
Blood. 2013 Apr 25;121(17):3375-85
pubmed: 23476048
Cell. 2013 May 9;153(4):785-96
pubmed: 23663778
Immunol Cell Biol. 2014 Jan;92(1):22-7
pubmed: 24145854
Int Immunol. 2014 Jan;26(1):3-11
pubmed: 24285828
J Immunol. 2014 Sep 1;193(5):2416-26
pubmed: 25057007
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14852-7
pubmed: 25267612
Immunity. 2014 Oct 16;41(4):529-42
pubmed: 25367570
Nat Rev Immunol. 2015 Mar;15(3):137-48
pubmed: 25656706
Immunity. 2015 Feb 17;42(2):356-366
pubmed: 25680275
J Hematol Oncol. 2015 Apr 14;8:35
pubmed: 25888530
J Allergy Clin Immunol. 2015 Nov;136(5):1387-97.e1-7
pubmed: 25962902
J Immunol. 2015 Aug 1;195(3):1006-14
pubmed: 26101322
Immunol Res. 2015 Dec;63(1-3):113-20
pubmed: 26376898
Immunol Rev. 2016 Mar;270(1):8-19
pubmed: 26864101
EBioMedicine. 2016 Jan 28;5:46-58
pubmed: 27077111
Elife. 2016 Sep 22;5:null
pubmed: 27657168
Trends Immunol. 2016 Dec;37(12):844-854
pubmed: 27793570
Front Immunol. 2016 Nov 23;7:520
pubmed: 27933060
Annu Rev Immunol. 2017 Apr 26;35:469-499
pubmed: 28226228
Sci Immunol. 2017 Dec 1;2(18):
pubmed: 29196450
Int J Mol Sci. 2018 Feb 06;19(2):null
pubmed: 29415483
Front Immunol. 2018 May 03;9:952
pubmed: 29774029
Front Immunol. 2018 Sep 27;9:2169
pubmed: 30319629
J Immunol. 2019 May 1;202(9):2535-2545
pubmed: 30858199
Nature. 1996 Nov 28;384(6607):364-7
pubmed: 8934523
J Exp Med. 1997 Jun 2;185(11):1909-18
pubmed: 9166420
Blood. 1997 Aug 15;90(4):1458-70
pubmed: 9269763
J Immunol. 1997 Oct 15;159(8):3707-16
pubmed: 9378956
J Immunol. 1998 Aug 1;161(3):1313-9
pubmed: 9686593
J Immunol. 1998 Sep 1;161(5):2223-31
pubmed: 9725215

Auteurs

Aurélie Bouteau (A)

Baylor Scott & White Research Institute, Baylor Institute for Immunology Research, Dallas, TX, United States.
Institute of Biomedical Studies, Baylor University, Waco, TX, United States.

Jérôme Kervevan (J)

Vaccine Research Institute, Créteil, France.
INSERM, Unité U955, Institut Mondor de Recherche Biomédicale, Créteil, France.
Faculté de Médecine, Université Paris-Est Créteil, Créteil, France.

Qingtai Su (Q)

Baylor Scott & White Research Institute, Baylor Institute for Immunology Research, Dallas, TX, United States.

Sandra M Zurawski (SM)

Baylor Scott & White Research Institute, Baylor Institute for Immunology Research, Dallas, TX, United States.
Vaccine Research Institute, Créteil, France.

Vanessa Contreras (V)

Vaccine Research Institute, Créteil, France.
CEA-Université Paris Sud 11-INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Nathalie Dereuddre-Bosquet (N)

Vaccine Research Institute, Créteil, France.
CEA-Université Paris Sud 11-INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Roger Le Grand (R)

Vaccine Research Institute, Créteil, France.
CEA-Université Paris Sud 11-INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.

Gerard Zurawski (G)

Baylor Scott & White Research Institute, Baylor Institute for Immunology Research, Dallas, TX, United States.
Vaccine Research Institute, Créteil, France.

Sylvain Cardinaud (S)

Vaccine Research Institute, Créteil, France.
INSERM, Unité U955, Institut Mondor de Recherche Biomédicale, Créteil, France.
Faculté de Médecine, Université Paris-Est Créteil, Créteil, France.

Yves Levy (Y)

Vaccine Research Institute, Créteil, France.
INSERM, Unité U955, Institut Mondor de Recherche Biomédicale, Créteil, France.
Faculté de Médecine, Université Paris-Est Créteil, Créteil, France.

Botond Z Igyártó (BZ)

Baylor Scott & White Research Institute, Baylor Institute for Immunology Research, Dallas, TX, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH